Report Overview
Global Surgical Navigation Systems Market is expected to grow at a CAGR of 6.1% during the forecast period 2024-2031.
Surgical navigation systems are an integral part of computer-assisted surgery (CAS). Computer-assisted surgery (CAS) represents a surgical concept and set of methods, that use computer technology for surgical planning, and for guiding or performing surgical interventions with accurate navigation during the procedure. Surgical navigation systems also assist in oral and maxillofacial surgery, orthopedic surgery, and visceral radiosurgery as well as implant dentistry. The feedback the system provides on the instrument location is particularly useful in situations where the surgeon doesn’t have clear visibility of the instrument, such as in minimally invasive surgeries.
Market Scope
| Metrics | Details |
| Market CAGR | 6.1% |
| Segments Covered | By Application, By Technology, By End-User, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
To Get a Free Sample Click here
Market Dynamics
The global surgical navigation systems market is primarily driven by the rising adoption of minimally invasive surgical procedures, the increasing number of orthopedic disorders, and cerebrovascular diseases, and the high prevalence of ENT disorders. For instance, in the U.S. there were 860,080 hip and knee replacement procedures done in 2016. According to the World Health Organization, 15 million people suffer strokes worldwide each year. Other factors positively affecting the market are Technological Advancements and New Product Launches coupled with the rise in regulatory approvals. Additionally, market opportunities in untapped Asian economies and the acceptance of surgical navigation systems in ambulatory settings will further propel the market.
However, the high cost of surgical navigation systems and product recalls in the recent past may hinder the market progress over the forecast period.
Market Segment Analysis
By application, the surgical navigation systems market is categorized into Neurosurgery, Orthopedic (Hip Replacement Implants and Knee Replacement), ENT, Dental, and Cardiac. The ENT segment holds a significant market share owing to rapid growth in the number of ENT-related surgeries such as Functional Endoscopic Sinus Surgeries (FESS). A large number of technological advancements in ENT surgical methodologies and an increase in the adoption of surgical navigation systems in ambulatory settings are expected to propel the market further. Neurology share holds the largest market share. It is attributed to the advantages associated with surgical navigation systems that help execute complex surgeries with improved accuracy and the early implementation of surgical navigation in this branch. According to the Brain Aneurysm Foundation, it is estimated that around 6 million people in the U.S. alone have an un-ruptured brain aneurysm and the annual rate of rupture is approximately 8 to 10 per 10,000 or about 30,000 people in the U.S. suffer an aneurysm rupture.
By Technology, the surgical navigation systems market is categorized into Optical Navigation Systems, Electromagnetic (EM) Navigation Systems, Hybrid Navigation Systems, CT-Based Navigation Systems, and Fluoroscopy-Based Navigation Systems. The Electromagnetic (EM) Navigation Systems segment holds the largest share of the market owing to its low cost and ease of use. Optical navigation systems share and show the highest CAGR growth due to their advantages over Electromagnetic Navigation Systems such as accuracy and reduced radiation exposure during complex surgeries. Additionally, the rise in awareness regarding the benefits of optical systems is also influencing the growth of the market.
Market Geographical Share
North America dominates the Surgical Navigation Systems market region-wise owing to the growing adoption of minimally invasive surgeries, the high prevalence of target disorders such as brain cancer, and orthopedic degenerative diseases, and increasing adoption by ambulatory settings. According to the American Cancer Society, an estimate for brain and spinal cord tumors in the United States in 2019 is roughly 23,820 malignant tumors of the brain, or spinal cord (13,410 in males and 10,410 in females) will be diagnosed. Other factors that propel this market are the availability of high investment and funding to support the development of rapid technological advancements, government funding for the development of surgical navigation systems, and increasing regulatory approvals. Moreover, its broad base of the patient population and the presence of significant medical companies along with the extensive research activities undertaken by a majority of prominent local players contribute to the growth of North America’s share in the Surgical Navigation Systems market.
Market Competitive Landscape
Key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. Regulatory approvals along with an increased focus on R&D are other ways the leading players improve their market presence.
In March 2019, Zimmer Biomet secured 510(k) clearance from the US Food and Drug Administration (FDA) for its ROSA ONE Spine System in robotically assisted surgeries. The device features 3D pre-operative planning tools and real-time, intraoperative data on soft tissue and bone anatomy. The knee surgery device is intended to improve bone cut accuracy and a range of motion gap analyses to boost flexion and restore natural joint movement potentially.
In February 2019, Medtronic launched the Mazor X Stealth Edition for spine surgery. The system offers a fully-integrated procedural solution for surgical planning, workflow, execution, and confirmation.
February 2019, Synaptive Medical, a global pioneer in automated surgical planning and robotics, has expanded its presence in Asia by providing hospitals in Thailand and Vietnam with its BrightMatter and Modus V product suite, a set of neurosurgery tools designed to unite surgical planning, imaging and navigation for more integrated brain and spine surgery and potentially improved patient outcomes.
In December 2018, the US Food and Drug Administration cleared Mariner Endosurgery’s LaparoGuard Augmented Surgical Navigation system for use in US operating rooms.
In December 2018, Medtronic announced it completed the acquisition of Israel-based Mazor Robotics. Medtronic's acquisition of Mazor ranks among the largest orthopedic deals completed in 2018 with a total value of the transaction reported at $1.7 billion. The acquisition strengthens Medtronic's position as a global innovator in enabling technologies for spine surgery by combining Medtronic's market-leading spine implants, navigation, and 3D imaging technology with Mazor's robotic-assisted surgery systems.
Trending Reports:
Virtual Reality (VR) In Medical Simulation Market
